Bridgeway Capital Management, LLC Magenta Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.41 - $0.86 $24,395 - $51,170	-59,500 Reduced 28.04%	152,700 $120,000
Q4 2022 Feb 14, 2023	BUY	$0.36 - $1.59 $23,400 - $103,350	65,000 Added 44.16%	212,200 $84,000
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $375,360 - $769,856	147,200 New	147,200 $427,000
Q1 2020 May 15, 2020	SELL	$6.03 - $15.24 $182,630 - $461,573	-30,287 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$9.63 - $14.0 $240,750 - $350,000	-25,000 Reduced 45.22%	30,287 $311,000
Q2 2019 Aug 14, 2019	SELL	$13.4 - $17.67 $599,154 - $790,078	-44,713 Reduced 44.71%	55,287 $815,000
Q1 2019 May 15, 2019	BUY	$5.7 - $19.7 $570,000 - $1.97 Million	100,000 New	100,000 $1.65 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.